Available Brands
Did you find this information helpful?
Author Details

Written By
P. Thirumal Reddy
B. Pharm

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)

Want to know more?
Read Our Editorial Policy
Quick Summary
FOSPHENYTOIN
Last updated on 31 Mar 2026 | 09:31 AM (IST)
FOSPHENYTOIN
Background and Date of approval FOSPHENYTOIN
Fosphenytoin was initially approved by the United States Food and Drug Administration (FDA) on September 30, 1996.
Uses of FOSPHENYTOIN
Fosphenytoin is primarily used to manage and prevent seizures in various contexts, including controlling generalized tonic-clonic (grand mal) seizures, complex partial (psychomotor or temporal lobe) seizures, and as a second-line treatment for status epilepticus—a medical emergency characterized by prolonged or repeated seizures. It is also employed in seizure prevention during neurosurgery and serves as an alternative to oral phenytoin, particularly in emergencies where rapid seizure control is crucial.
How is FOSPHENYTOIN administered?
Fosphenytoin is primarily administered intravenously (IV) or, in certain cases, intramuscularly (IM). Intravenous administration involves slowly infusing the medication into a vein, while intramuscular administration entails injecting it into a muscle. The route choice depends on factors such as the patient's condition, urgency of treatment, and accessibility of veins. Intravenous administration allows for rapid delivery, making it suitable for emergencies, while intramuscular administration provides an alternative when intravenous access is difficult. Proper technique and medical supervision are crucial for safe and effective administration, regardless of the chosen route.
Side Effects of FOSPHENYTOIN
Fosphenytoin use can lead to a range of side effects. Common side effects encompass gastrointestinal disturbances, skin reactions, fatigue, dizziness, muscle and joint pain, and changes in appetite. Serious side effects are rare but may include allergic reactions, neurological effects, eye-related symptoms, and potential liver impacts. Adhering to prescribed dosages, promptly reporting severe reactions, and consulting a healthcare provider is crucial to ensure this medication's safe and effective use.
Warnings
The medication may lead to cardiac effects, including heart rhythm disturbances and hypotension. Liver problems, blood disorders, and respiratory depression are also possible. Fosphenytoin can affect mental alertness and coordination, potentially impairing activities like driving. Abruptly stopping this medication can increase seizure risk, and individuals with a history of drug-related rash (e.g., with phenytoin) are at a higher risk of developing a similar reaction. Its use includes potential bone health effects, such as decreased bone mineral density and an increased risk of osteoporosis, particularly with long-term use. Gum hypertrophy (enlargement) may occur, especially with prolonged treatment. This medication can lower vitamin D levels and affect calcium metabolism, potentially impacting bone health.
Precautions
If you experience a skin rash, itching, swelling, or any signs of allergic reactions, promptly notify your healthcare provider. Discontinue fosphenytoin and seek medical attention if severe reactions occur. Individuals with heart conditions should be closely monitored for irregular heartbeats, dizziness, or fainting. Blood pressure should be regularly assessed during treatment. Regular liver function and blood cell count tests are essential, especially if you have a history of liver or blood disorders. Report any unusual symptoms to your doctor.Discuss bone health strategies with your healthcare provider, such as calcium and vitamin D supplementation and weight-bearing exercises, to mitigate potential bone-related effects.
Word of Advice
Individuals with hypersensitivity to fosphenytoin or phenytoin should avoid its use, and vigilant monitoring for allergic reactions, cardiac effects, and hypotension is advised. Regular liver and kidney function assessments are crucial, especially in patients with pre-existing conditions. Blood disorders, respiratory issues, and potential interactions with alcohol and other medications should be carefully monitored and discussed with a healthcare provider. Pregnant or breastfeeding individuals should seek medical guidance due to potential fetal and infant risks. Activities requiring alertness, such as driving, may be impaired due to dizziness or drowsiness caused by this medication. Considerations extend to bone health, diet, mental health, and potential drug interactions, with medical oversight being particularly important for the geriatric and pediatric populations. Genetic factors, immunization effects, and proper storage should also be considered, along with formulating an emergency plan and using medical alert information.
Frequently Asked Questions
Q1.
Can I travel while taking fosphenytoin?
Travel is possible while taking fosphenytoin, but it's important to plan. Ensure you have an adequate supply, follow your dosing schedule, and carry the necessary medical information.
Q2.
What should I do if I experience a seizure while taking fosphenytoin?
If you experience a seizure, follow your doctor's guidance and any seizure action plan you have in place. Contact your healthcare provider for further evaluation and management.
Q3.
Can Fosphenytoin cause vision problems?
Fosphenytoin can cause visual disturbances, including blurred vision. If you experience significant vision changes, consult your doctor.
Q4.
Can I suddenly stop taking Fosphenytoin?
Abruptly discontinuing fosphenytoin can lead to increased seizure activity. Any changes to your medication regimen should be made under medical supervision.
Q5.
Can Fosphenytoin Cause Changes in Mood or Behavior?
Fosphenytoin can affect mood and behavior, potentially leading to irritability, anxiety, or depression. Report any significant changes to your healthcare provider.
Q6.
Is Fosphenytoin Addictive?
No, fosphenytoin is not considered an addictive medication. It is used to control seizures and is not associated with addictive properties.
References
- Pfizer Limited, US Food & Drug Administration, [Revised on 3/2017] [Accessed on 9th Aug 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020450s003lbl.pdf
- Pfizer Limited, Electronic Medicines Compendium (EMC), [Revised on 15th Jun 2023] [Accessed on 9th Aug 2023], https://www.medicines.org.uk/emc/product/2260/smpc#gref
- Roger J. Porter & Michael A. Rogawski, Antiseizure Drugs, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 409-439.
- Misty D. Smith, Cameron S. Metcalf, and Karen S. Wilcox, Pharmacotherapy of the Epilepsies, Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 13th Edition, 2018, 303-326.
Disclaimer
The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.






